000 | 01792 a2200445 4500 | ||
---|---|---|---|
005 | 20250511175836.0 | ||
264 | 0 | _c19920407 | |
008 | 199204s 0 0 eng d | ||
022 | _a0027-8424 | ||
024 | 7 |
_a10.1073/pnas.89.5.1978 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aXu, H | |
245 | 0 | 0 |
_aOpioid enhancement of evoked [Met5]enkephalin release requires activation of cholinergic receptors: possible involvement of intracellular calcium. _h[electronic resource] |
260 |
_bProceedings of the National Academy of Sciences of the United States of America _cMar 1992 |
||
300 |
_a1978-82 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _a3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAtropine _xpharmacology |
650 | 0 | 4 |
_aCalcimycin _xpharmacology |
650 | 0 | 4 |
_aCalcium _xphysiology |
650 | 0 | 4 |
_aColforsin _xpharmacology |
650 | 0 | 4 | _aEnkephalin, D-Penicillamine (2,5)- |
650 | 0 | 4 |
_aEnkephalin, Methionine _xmetabolism |
650 | 0 | 4 |
_aEnkephalins _xpharmacology |
650 | 0 | 4 | _aEvoked Potentials |
650 | 0 | 4 |
_aFentanyl _xanalogs & derivatives |
650 | 0 | 4 | _aGuinea Pigs |
650 | 0 | 4 |
_aHexamethonium Compounds _xpharmacology |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aMyenteric Plexus _xphysiology |
650 | 0 | 4 |
_aNaloxone _xpharmacology |
650 | 0 | 4 |
_aPyrrolidines _xpharmacology |
650 | 0 | 4 |
_aReceptors, Muscarinic _xphysiology |
650 | 0 | 4 |
_aReceptors, Opioid _xdrug effects |
650 | 0 | 4 | _aSufentanil |
700 | 1 | _aGintzler, A R | |
773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 89 _gno. 5 _gp. 1978-82 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.89.5.1978 _zAvailable from publisher's website |
999 |
_c1318381 _d1318381 |